Relationship Between Psychosocial Factors and Tremor Severity in Essential Tremor
Objective: To examine the relationship between psychosocial factors and tremor severity in patients with essential tremor (ET). Background: Essential tremor is one of the most…Metabolic Syndrome is not Associated with Parkinson’s Disease Severity, but Individual Metabolic Components May Be
Objective: To investigate whether individual metabolic components are associated with motor, cognitive, and functional outcomes in Parkinson’s disease (PD). Background: Metabolic syndrome has been proposed…Online Assessments Measure Motor and Cognitive Progression in People with and without Parkinson’s Disease
Objective: To evaluate longitudinal progression in online participant reported outcomes (PROs) among people with Parkinson’s disease (PD), prodromal PD, and healthy controls. Background: Collecting PROs…The Lewy Body Dementia Domain Rating Scale (LBD-DRS): Patient and Care Partner Perspectives
Objective: To develop and validate the Lewy Body Dementia Domain Rating Scale (LBD-DRS), a disease-specific outcome measure designed to comprehensively capture the clinical features and…Challenges of Translating the MDS-UPDRS into Ukrainian During Wartime
Objective: To describe the practical, linguistic, and logistical challenges encountered during the Ukrainian translation and cultural adaptation of the MDS-UPDRS. Background: The process of translating…Clinical Outcome Assessments for Psychiatric Manifestations in Dystonia: Systematic Review, Critique, and Recommendations
Objective: An International Parkinson and Movement Disorder Society subcommittee aimed to assess the quality of severity and screening instruments for depression, anxiety, apathy, OCD, mania,…Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) Reveals Clinically Meaningful Functional Progression and Quality-of-Life Impact in Parkinson’s Disease
Objective: To evaluate the utility of the Neuronal aSynuclein Disease Integrated Staging System (NSD-ISS) in assessing the meaningfulness of stage progression, and associations with quality…Clinical Outcome Assessments for Spasticity and Functional Performance in Spastic Paresis: Which Scales Should Be Used?
Objective: To review clinical outcome assessments (COAs) used to evaluate spasticity and functional impairment in spastic paresis and provide recommendations for their use in clinical…Item – Level Drivers of Certification Failure in the MDS-UPDRS Motor Examination: A Five-Year Global Analysis
Objective: To identify individual Part III items that disproportionately contribute to first-attempt certification failure and to evaluate the stability of these patterns over five years.…Clinical instability and fluctuations as an early marker of accelerated progression
Objective: To determine whether early clinical instability, quantified through combined motor and non-motor fluctuations, predicts a more severe longitudinal disease course in Parkinson’s disease. Background:…
- 1
- 2
- 3
- …
- 39
- Next Page »